SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-033607
Filing Date
2018-06-08
Accepted
2018-06-08 17:25:12
Documents
2
Period of Report
2018-06-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv496091_4.html 4  
1 OWNERSHIP DOCUMENT tv496091_4.xml 4 4245
2 POWER OF ATTORNEY tv496091_ex24.htm EX-24 5628
  Complete submission text file 0001144204-18-033607.txt   11242
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2575 W. BELLFORT SUITE 333 HOUSTON TX 77054
Business Address
George Robert E. (Reporting) CIK: 0001674701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37758 | Film No.: 18890455